Categories Earnings, Health Care

CVS Health Corporation builds on its strong growth in Q3

Building on the strong momentum it has been displaying since the beginning of this year, CVS Health Corporation (NYSE: CVS) on Wednesday posted third-quarter financial results that were ahead of Wall Street targets.

The company said its total revenue shot up 36.5% to  $64.8 billion, exceeding average analysts’ consensus of $63 billion.

 CVS Health Q3 2019 Earnings Infographic

The strong growth in topline helped the healthcare company generate adjusted EPS of $1.84 per share in Q3, which was 7 cents ahead of the street consensus.

“All of our core businesses performed in line with or above expectations, reflecting strong operational execution. As a result, we delivered strong growth and generated robust operating cash flow, which enabled us to continue to deliver while returning capital to our shareholders,” CEO Larry Merlo stated.

READ: Alteryx CFO Kevin Rubin on Q4 outlook, stock sell-off and the possibility of getting acquired

Outlook raised

Thanks to the strong results, the company raised and narrowed its Adjusted EPS guidance range to $6.97 – $7.05 from the prior projection of $6.89 – $7.00.

Meanwhile, outlook on GAAP operating income was slashed to $11.77 billion – $11.95 billion from the earlier range of $11.82 billion – $12.02 billion.

CVS shares gained 1.5% during pre-market hours.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Comments

  1. Pingback: MineFullTrader
  2. Pingback: bergader
  3. Pingback: male masturbation
  4. Pingback: Glock 48
  5. Pingback: learn more
  6. Pingback: Cake carts
  7. Pingback: junk cars
  8. Pingback: FLINTLOCK PISTOL
  9. Pingback: ps5 on sale
  10. Pingback: penis girth sleeve
  11. Pingback: kruideniertje
  12. Pingback: mushrooms for sale
  13. Pingback: economics
  14. Pingback: Google
  15. Pingback: learn more
  16. Pingback: Haupia strain
  17. Pingback: Platinum haupia
  18. Pingback: Bubble hash
  19. Pingback: Moroccan hash
  20. Pingback: Litto disposable
  21. Pingback: Bubble hash
  22. Pingback: bahis siteleri
  23. Pingback: 3skylight
  24. Pingback: University of Embu
  25. Pingback: A片
  26. Pingback: must courses
  27. Pingback: MUT
  28. Pingback: ABCD 1
  29. Pingback: crypto wallet
  30. Pingback: rush dresses 2022
  31. Pingback: aplikasi judi slot
  32. Pingback: HaanGlas VIG
  33. Pingback: indobet slot
  34. Pingback: Glucotrust Reviews
  35. Pingback: vn88 đăng nhập
  36. Pingback: TVET programmes
  37. Pingback: Diploma Programmes
  38. Pingback: roulette simulator

Comments are closed.

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top